Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Se Hoon Kim

Showing results (391-400 of 481) with videos related to

Pageof 49
Sort By:
Neurosurgery|April 29, 2021
Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter StudyYae Won Park, Ji Eun Park, Sung Soo Ahn, et al.
Journal of Neuro-Oncology|May 22, 2026
Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigmIn-Ho Jung, Jihwan Yoo, Seonah Choi, et al.
Neuro-Oncology|May 4, 2026
A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in IDH-mutant astrocytoma patientsMinjee Cho, Minjin Kim, Hyeonjin Kim, et al.
Neuron|June 26, 2018
Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical DyslaminationSang Min Park, Jae Seok Lim, Suresh Ramakrishina, et al.
Journal of Molecular Endocrinology|November 5, 2021
Downregulation of miR-216a-5p and miR-652-3p is associated with growth and invasion by targeting JAK2 and PRRX1 in GH-producing pituitary tumoursYang Jong Lee, Chan Woo Kang, Ju Hun Oh, et al.
Journal of Neuro-Oncology|August 21, 2022
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classificationMinjae Kim, Sooyon Kim, Yae Won Park, et al.
Journal of Neuro-Oncology|February 25, 2023
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalitiesYae Won Park, Kyunghwa Han, Sooyon Kim, et al.
Oncotarget|November 21, 2017
Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphomaHyunsoo Cho, Se Hoon Kim, Soo-Jeong Kim, et al.
Cancer Research and Treatment|April 24, 2020
Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic GliomasJe Beom Hong, Tae Hoon Roh, Seok-Gu Kang, et al.
Cancer Research and Treatment|December 1, 2023
Long-term Outcomes of Protocol-Based Treatment for Newly Diagnosed MedulloblastomaWon Kee Ahn, Seung Min Hahn, Hong In Yoon, et al.
Pageof 49

Showing results (391-400 of 481) with videos related to

Sort By:
Pageof 49
Neurosurgery|April 29, 2021
Magnetic Resonance Imaging Parameters for Noninvasive Prediction of Epidermal Growth Factor Receptor Amplification in Isocitrate Dehydrogenase-Wild-Type Lower-Grade Gliomas: A Multicenter StudyYae Won Park, Ji Eun Park, Sung Soo Ahn, et al.
Journal of Neuro-Oncology|May 22, 2026
Survival analysis of adult midline-located gliomas and diffuse midline gliomas: beyond the H3K27 mutation paradigmIn-Ho Jung, Jihwan Yoo, Seonah Choi, et al.
Neuro-Oncology|May 4, 2026
A comprehensive clinical, molecular, radiological, and surgical analysis for predicting prognosis in IDH-mutant astrocytoma patientsMinjee Cho, Minjin Kim, Hyeonjin Kim, et al.
Neuron|June 26, 2018
Brain Somatic Mutations in MTOR Disrupt Neuronal Ciliogenesis, Leading to Focal Cortical DyslaminationSang Min Park, Jae Seok Lim, Suresh Ramakrishina, et al.
Journal of Molecular Endocrinology|November 5, 2021
Downregulation of miR-216a-5p and miR-652-3p is associated with growth and invasion by targeting JAK2 and PRRX1 in GH-producing pituitary tumoursYang Jong Lee, Chan Woo Kang, Ju Hun Oh, et al.
Journal of Neuro-Oncology|August 21, 2022
Sex as a prognostic factor in adult-type diffuse gliomas: an integrated clinical and molecular analysis according to the 2021 WHO classificationMinjae Kim, Sooyon Kim, Yae Won Park, et al.
Journal of Neuro-Oncology|February 25, 2023
Revisiting prognostic factors in glioma with leptomeningeal metastases: a comprehensive analysis of clinical and molecular factors and treatment modalitiesYae Won Park, Kyunghwa Han, Sooyon Kim, et al.
Oncotarget|November 21, 2017
Programmed cell death 1 expression is associated with inferior survival in patients with primary central nervous system lymphomaHyunsoo Cho, Se Hoon Kim, Soo-Jeong Kim, et al.
Cancer Research and Treatment|April 24, 2020
Survival, Prognostic Factors, and Volumetric Analysis of Extent of Resection for Anaplastic GliomasJe Beom Hong, Tae Hoon Roh, Seok-Gu Kang, et al.
Cancer Research and Treatment|December 1, 2023
Long-term Outcomes of Protocol-Based Treatment for Newly Diagnosed MedulloblastomaWon Kee Ahn, Seung Min Hahn, Hong In Yoon, et al.
Pageof 49